
<document id="DBMI.pac47" origId="pac47">
	<sentence id="DBMI.pac47.s0" origId="s0" text="Many drugs, including most drugs effective in the treatment of major depressive disorder (paroxetine, other SSRIs, and many tricyclics), are metabolized by the cytochrome P450 isozyme CYP2D6."/>
	<sentence id="DBMI.pac47.s1" origId="s1" text="Like other agents that are metabolized by CYP2D6, paroxetine may significantly inhibit the activity of this isozyme."/>
	<sentence id="DBMI.pac47.s2" origId="s2" text="In most patients (&gt;90%), this CYP2D6 isozyme is saturated early during paroxetine dosing."/>
	<sentence id="DBMI.pac47.s3" origId="s3" text="In 1 study, daily dosing of immediate-release paroxetine  (20 mg once daily) under steady-state conditions increased single-dose desipramine (100 mg) Cmax, AUC, and T by an average of approximately 2-, 5-, and 3-fold, respectively.">
		<entity charOffset="445-456" id="DBMI.pac47.s3.e0" origId="s3.e0" text="paroxetine " type="Active ingredient"/>
		<entity charOffset="528-540" id="DBMI.pac47.s3.e1" origId="s3.e1" text="desipramine " type="Active ingredient"/>
		<pair e1="DBMI.pac47.s3.e0" e2="DBMI.pac47.s3.e1" id="DBMI.pac47.s3.p0" interaction="true" interactionPhraseType="Quantitative" modality="Positive" object="desipramine " precipitant="paroxetine "/>
		<pair e1="DBMI.pac47.s3.e1" e2="DBMI.pac47.s3.e0" id="DBMI.pac47.s3.p1" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
	</sentence>
	<sentence id="DBMI.pac47.s4" origId="s4" text="Concomitant use of paroxetine with risperidone, a CYP2D6 substrate has also been evaluated."/>
	<sentence id="DBMI.pac47.s5" origId="s5" text="In 1 study, daily dosing of paroxetine 20 mg in patients stabilized on risperidone (4 to 8 mg/day) increased mean plasma concentrations of risperidone approximately 4-fold, decreased 9-hydroxyrisperidone concentrations approximately 10%, and increased concentrations of the active moiety (the sum of risperidone plus 9-hydroxyrisperidone) approximately 1.4-fold.">
		<entity charOffset="752-763" id="DBMI.pac47.s5.e0" origId="s5.e0" text="paroxetine " type="Active ingredient"/>
		<entity charOffset="1024-1036" id="DBMI.pac47.s5.e1" origId="s5.e1" text="risperidone " type="Active ingredient"/>
		<entity charOffset="907-928" id="DBMI.pac47.s5.e2" origId="s5.e2" text="9-hydroxyrisperidone " type="Metabolite"/>
		<pair e1="DBMI.pac47.s5.e0" e2="DBMI.pac47.s5.e1" id="DBMI.pac47.s5.p0" interaction="true" interactionPhraseType="Quantitative" modality="Positive" object="risperidone " precipitant="paroxetine "/>
		<pair e1="DBMI.pac47.s5.e0" e2="DBMI.pac47.s5.e1" id="DBMI.pac47.s5.p1" interaction="true" interactionPhraseType="Quantitative" modality="Positive" object="risperidone " precipitant="paroxetine "/>
		<pair e1="DBMI.pac47.s5.e0" e2="DBMI.pac47.s5.e2" id="DBMI.pac47.s5.p2" interaction="true" interactionPhraseType="Quantitative" modality="Positive" object="9-hydroxyrisperidone " precipitant="paroxetine "/>
		<pair e1="DBMI.pac47.s5.e1" e2="DBMI.pac47.s5.e0" id="DBMI.pac47.s5.p3" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac47.s5.e1" e2="DBMI.pac47.s5.e2" id="DBMI.pac47.s5.p4" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac47.s5.e2" e2="DBMI.pac47.s5.e0" id="DBMI.pac47.s5.p5" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac47.s5.e2" e2="DBMI.pac47.s5.e1" id="DBMI.pac47.s5.p6" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
	</sentence>
	<sentence id="DBMI.pac47.s6" origId="s6" text="The effect of paroxetine on the pharmacokinetics of atomoxetine has been evaluated when both drugs were at steady state."/>
	<sentence id="DBMI.pac47.s7" origId="s7" text="In healthy volunteers who were extensive metabolizers of CYP2D6, paroxetine 20 mg daily was given in combination with 20 mg atomoxetine every 12 hours.">
		<entity charOffset="1273-1284" id="DBMI.pac47.s7.e0" origId="s7.e0" text="paroxetine " type="Active ingredient"/>
		<entity charOffset="1464-1476" id="DBMI.pac47.s7.e1" origId="s7.e1" text="atomoxetine " type="Active ingredient"/>
		<pair e1="DBMI.pac47.s7.e0" e2="DBMI.pac47.s7.e1" id="DBMI.pac47.s7.p0" interaction="true" interactionPhraseType="Quantitative" modality="Positive" object="atomoxetine " precipitant="paroxetine "/>
		<pair e1="DBMI.pac47.s7.e0" e2="DBMI.pac47.s7.e1" id="DBMI.pac47.s7.p1" interaction="true" interactionPhraseType="Quantitative" modality="Positive" object="atomoxetine " precipitant="paroxetine "/>
		<pair e1="DBMI.pac47.s7.e1" e2="DBMI.pac47.s7.e0" id="DBMI.pac47.s7.p2" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
	</sentence>
	<sentence id="DBMI.pac47.s8" origId="s8" text="This resulted in increases in steady state atomoxetine AUC values that were 6- to 8-fold greater and in atomoxetine Cmax values that were 3- to 4-fold greater than when atomoxetine was given alone."/>
	<sentence id="DBMI.pac47.s9" origId="s9" text="Dosage adjustment of atomoxetine may be necessary and it is recommended that atomoxetine be initiated at a reduced dose when given with paroxetine."/>
	<sentencespan id="DBMI.pac47.sp0" origId="sp0" text="Many drugs, including most drugs effective in the treatment of major depressive disorder (paroxetine, other SSRIs, and many tricyclics), are metabolized by the cytochrome P450 isozyme CYP2D6. Like other agents that are metabolized by CYP2D6, paroxetine may significantly inhibit the activity of this isozyme. In most patients (&gt;90%), this CYP2D6 isozyme is saturated early during paroxetine dosing."/>
	<sentencespan id="DBMI.pac47.sp1" origId="sp1" text="In 1 study, daily dosing of immediate-release paroxetine  (20 mg once daily) under steady-state conditions increased single-dose desipramine (100 mg) Cmax, AUC, and T by an average of approximately 2-, 5-, and 3-fold, respectively. Concomitant use of paroxetine with risperidone, a CYP2D6 substrate has also been evaluated. In 1 study, daily dosing of paroxetine 20 mg in patients stabilized on risperidone (4 to 8 mg/day) increased mean plasma concentrations of risperidone approximately 4-fold, decreased 9-hydroxyrisperidone concentrations approximately 10%, and increased concentrations of the active moiety (the sum of risperidone plus 9-hydroxyrisperidone) approximately 1.4-fold.">
		<entity charOffset="445-456" id="DBMI.pac47.sp1.e0" origId="sp1.e0" text="paroxetine " type="Active ingredient"/>
		<entity charOffset="528-540" id="DBMI.pac47.sp1.e1" origId="sp1.e1" text="desipramine " type="Active ingredient"/>
		<entity charOffset="1024-1036" id="DBMI.pac47.sp1.e2" origId="sp1.e2" text="risperidone " type="Active ingredient"/>
		<entity charOffset="907-928" id="DBMI.pac47.sp1.e3" origId="sp1.e3" text="9-hydroxyrisperidone " type="Metabolite"/>
		<pair e1="DBMI.pac47.sp1.e0" e2="DBMI.pac47.sp1.e1" id="DBMI.pac47.sp1.p0" interaction="true" interactionPhraseType="Quantitative" modality="Positive" object="desipramine " precipitant="paroxetine "/>
		<pair e1="DBMI.pac47.sp1.e0" e2="DBMI.pac47.sp1.e2" id="DBMI.pac47.sp1.p1" interaction="true" interactionPhraseType="Quantitative" modality="Positive" object="risperidone " precipitant="paroxetine "/>
		<pair e1="DBMI.pac47.sp1.e0" e2="DBMI.pac47.sp1.e2" id="DBMI.pac47.sp1.p2" interaction="true" interactionPhraseType="Quantitative" modality="Positive" object="risperidone " precipitant="paroxetine "/>
		<pair e1="DBMI.pac47.sp1.e0" e2="DBMI.pac47.sp1.e3" id="DBMI.pac47.sp1.p3" interaction="true" interactionPhraseType="Quantitative" modality="Positive" object="9-hydroxyrisperidone " precipitant="paroxetine "/>
		<pair e1="DBMI.pac47.sp1.e1" e2="DBMI.pac47.sp1.e0" id="DBMI.pac47.sp1.p4" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac47.sp1.e1" e2="DBMI.pac47.sp1.e2" id="DBMI.pac47.sp1.p5" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac47.sp1.e1" e2="DBMI.pac47.sp1.e3" id="DBMI.pac47.sp1.p6" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac47.sp1.e2" e2="DBMI.pac47.sp1.e0" id="DBMI.pac47.sp1.p7" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac47.sp1.e2" e2="DBMI.pac47.sp1.e1" id="DBMI.pac47.sp1.p8" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac47.sp1.e2" e2="DBMI.pac47.sp1.e3" id="DBMI.pac47.sp1.p9" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac47.sp1.e3" e2="DBMI.pac47.sp1.e0" id="DBMI.pac47.sp1.p10" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac47.sp1.e3" e2="DBMI.pac47.sp1.e1" id="DBMI.pac47.sp1.p11" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac47.sp1.e3" e2="DBMI.pac47.sp1.e2" id="DBMI.pac47.sp1.p12" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
	</sentencespan>
	<sentencespan id="DBMI.pac47.sp2" origId="sp2" text="The effect of paroxetine on the pharmacokinetics of atomoxetine has been evaluated when both drugs were at steady state. In healthy volunteers who were extensive metabolizers of CYP2D6, paroxetine 20 mg daily was given in combination with 20 mg atomoxetine every 12 hours. This resulted in increases in steady state atomoxetine AUC values that were 6- to 8-fold greater and in atomoxetine Cmax values that were 3- to 4-fold greater than when atomoxetine was given alone.">
		<entity charOffset="1273-1284" id="DBMI.pac47.sp2.e0" origId="sp2.e0" text="paroxetine " type="Active ingredient"/>
		<entity charOffset="1464-1476" id="DBMI.pac47.sp2.e1" origId="sp2.e1" text="atomoxetine " type="Active ingredient"/>
		<pair e1="DBMI.pac47.sp2.e0" e2="DBMI.pac47.sp2.e1" id="DBMI.pac47.sp2.p0" interaction="true" interactionPhraseType="Quantitative" modality="Positive" object="atomoxetine " precipitant="paroxetine "/>
		<pair e1="DBMI.pac47.sp2.e0" e2="DBMI.pac47.sp2.e1" id="DBMI.pac47.sp2.p1" interaction="true" interactionPhraseType="Quantitative" modality="Positive" object="atomoxetine " precipitant="paroxetine "/>
		<pair e1="DBMI.pac47.sp2.e1" e2="DBMI.pac47.sp2.e0" id="DBMI.pac47.sp2.p2" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
	</sentencespan>
	<sentencespan id="DBMI.pac47.sp3" origId="sp3" text="Dosage adjustment of atomoxetine may be necessary and it is recommended that atomoxetine be initiated at a reduced dose when given with paroxetine."/>
</document>
